PT Kimia Farma Persero Tbk (ISX:KAEF) Owner Earnings per Share (TTM): -58.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Persero Tbk ISX:KAEF
57 GF Score
Price Rp432.00
GF Value Rp579.40
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Persero Tbk Owner Earnings per Share (TTM)?

PT Kimia Farma Persero Tbk ISX:KAEF -0.92% 57 Owner Earnings per Share (TTM) is -58.25 as of Jun. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 57/100 and a GF Value™ of Rp579.40 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 61 Medical Distribution companies, PT Kimia Farma Persero Tbk ranks worse than 1639342.62% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) ended in Jun. 2026 was Rp-58.25. It's Price-to-Owner-Earnings ratio for today is 0.


The historical rank and industry rank for PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of PT Kimia Farma Persero Tbk was 1730.28. The lowest was 50.24. And the median was 106.13.


ISX:KAEF's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 14.83
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

PT Kimia Farma Persero Tbk's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was Rp-11.52. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was Rp-41.25. It's PE Ratio (TTM) ratio for today is At Loss.

PT Kimia Farma Persero Tbk's EPS without NRI for the three months ended in Jun. 2026 was Rp-9.91. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was Rp-103.24. It's PE Ratio without NRI ratio for today is At Loss.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


PT Kimia Farma Persero Tbk Owner Earnings per Share (TTM) Related Terms


PT Kimia Farma Persero Tbk Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Persero Tbk Owner Earnings per Share (TTM) Chart

PT Kimia Farma Persero Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.00 -130.38 -417.97 -184.61 -81.37

PT Kimia Farma Persero Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -158.59 -128.18 -81.37 -55.49 -58.25

ISX:KAEF vs MCK, COR, CAH: Owner Earnings per Share (TTM) Comparison

For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Persero Tbk Price-to-Owner-Earnings vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Persero Tbk's Price-to-Owner-Earnings falls into.


ISX:KAEF
57GF Score
PT Kimia Farma Persero Tbk ISX:KAEF
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Persero Tbk Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income -229,618
Depreciation, Depletion and Amortization 403,486
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 498,098
Change In Working Capital 0
Shares Outstanding (Diluted Average) 5,567

1. Start with "Net Income" from income statement. PT Kimia Farma Persero Tbk's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was Rp-229,618 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. PT Kimia Farma Persero Tbk's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was Rp403,486 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. PT Kimia Farma Persero Tbk's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was Rp0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = Rp498,098 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

PT Kimia Farma Persero Tbk's 5-Year Average Maintenance Capital Expenditure = Rp498,098 Mil

5. "Change In Working Capital" is from cashflow statement. PT Kimia Farma Persero Tbk's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was Rp0 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. PT Kimia Farma Persero Tbk's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 5566.588 Mil.

PT Kimia Farma Persero Tbk's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( -229618.337 +403485.835+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-498098.38952426+0)/5566.588
=-58.25

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=432.00/-58.25
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of -58.25 mean?
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Owner Earnings per Share (TTM) of -58.25 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on PT Kimia Farma Persero Tbk. According to the industry distribution chart, PT Kimia Farma Persero Tbk ranks #999999 out of 61 companies in the Medical Distribution industry.
Is PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) too high?
PT Kimia Farma Persero Tbk's current Owner Earnings per Share (TTM) is -58.25. Based on the distribution chart, PT Kimia Farma Persero Tbk ranks #999999 out of 61 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Owner Earnings per Share (TTM) compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Persero Tbk ranks #999999 out of 61 companies for Owner Earnings per Share (TTM). This places PT Kimia Farma Persero Tbk in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 14.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Distribution company?
The median Owner Earnings per Share (TTM) among Medical Distribution companies is 14.83, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on PT Kimia Farma Persero Tbk. For the Medical Distribution industry, the median Owner Earnings per Share (TTM) is 14.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Persero Tbk's current Owner Earnings per Share (TTM) is -58.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.40, compared to a current price of Rp432.00 — trading 25.4% below its estimated fair value. The current Owner Earnings per Share (TTM) is -58.25. PT Kimia Farma Persero Tbk's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Owner Earnings per Share (TTM) is -58.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued. The current stock price of Rp432.00 is trading 25.4% below its estimated GF Value™ of Rp579.40. GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Owner Earnings per Share (TTM): -58.25
  • GF Value™: Rp579.40 vs. price of Rp432.00 (25.4% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kimia Farma Persero Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
57GF Score

Get the complete analysis for ISX:KAEF

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp432.00
Price
Rp579.40
GF Value